HFN Acted as Israeli Counsel for a Consortium of Banks in a 4.5 Billion Debt Offering by Teva Pharmaceutical Industries Ltd.
Categories: Capital Markets, Corporate and M&A, Tax
Teva Pharmaceuticals Industries Limited announced on March 7th 2018, the pricing of an offering of $4.5 Billion senior notes. HFN acted as Israeli Counsel for Barclays Bank Plc, Citigroup Global Markets Limited, Merrill Lynch International, Credit Suisse Securities, HSBC Bank plc, and BNP Paribas as the joint book-runners and managers of the offering. This offering required the cooperation of the Corporate Department led by Ron Ben-Menachem, Ory Nacht, Stav Harel and May Dahan, as well as the Tax Department led by Yuval Navot, Eldad Chamam, Ehab Farah and Eitan Ella.
